Skip to search formSkip to main contentSkip to account menu

CRT 0066101

Known as: CRT-0066101, CRT0066101 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Background/Aims: Breast cancer is clinically classified into three main subtypes: estrogen receptor-positive (ER+) breast cancer… 
2019
2019
Acute lymphoblastic leukemia (ALL) is the leading cause of cancer related death in children, and cure rates for relapsed… 
2018
2018
CRT0066101 is an inhibitor of protein kinase D with anti-tumor activity in several types of human carcinomas. However, the effect… 
2014
2014
During production, an error was introduced to the fourth sentence of the Abstract. The correct sentence reads: "Cell treatment… 
2014
2014
Resistance to imatinib (IM) has posed a great obstacle in treating Chronic Myeloid Leukemia(CML). New generations of tyrosine… 
2013
2013
We examined whether protein kinase D1 (PKD1) mediates negative feeback of PI3K/Akt signaling in intestinal epithelial cells… 
2012
2012
We have examined the role of protein kinase D1 (PKD1) signaling in intestinal epithelial cell migration. Wounding monolayer… 
2011
2011
Novel protein kinase C isoforms (PKC δ and ε) mediate early events in acute pancreatitis. Protein kinase D (PKD/PKD1) is a…